Key result
In 66 patients with somatic soft tissue leiomyosarcoma, 50% died at a mean of 3 years, with tumor size, stage, and anatomic site identified as factors increasing the death rate.
Why the study?
Does surgery with adjunctive agents improve survival compared to surgery alone in patients with somatic soft tissue leiomyosarcoma?
Observational (n=66)
No
Does surgery with adjunctive agents improve survival compared to surgery alone in patients with somatic soft tissue leiomyosarcoma?
In patients with somatic soft tissue leiomyosarcoma, tumor size and stage are key prognostic factors, and adjunctive therapy added to surgery may improve survival.
High early mortality highlights poor prognosis in somatic soft tissue leiomyosarcoma; supports risk stratification by size and stage but leaves open optimal adjunctive strategies.
Leiomyosarcoma is a rare, aggressively malignant connective tissue tumor of mature adults, which arises from smooth muscle. It occurs most frequently in the uterus, bowel, vascular tissues, and less commonly in somatic soft tissue or bone. The tumor when it arises in soft tissue has distinctive histologic features which somewhat resemble malignant fibrous histiocytoma (otherwise known as myxofibrosarcoma). The Orthopaedic Oncology Service at our institution has treated 66 patients with these lesions and thus far, 1/2 of the patients have died of disease at a mean of 3 years after discovery. Factors that increase the death rate include size of the tumor, Musculoskeletal Tumor Society Stage of disease, and to a lesser extent particularly in the lower extremities, anatomic site. Radiation and chemotherapy had little direct effect on the outcome but patients treated with surgery and adjunctive agents seemed to live longer than their cohorts treated with surgery alone. The purpose of this study is a general review of the clinical and prognostic features of this cancer.
No takes yet. Share an insight, caveat, or question.
Mankin et al. (2004) conducted an observational in Leiomyosarcoma of somatic soft tissues (n=66). Surgery and adjunctive agents vs. Surgery alone was evaluated on Death from disease. In 66 patients with somatic soft tissue leiomyosarcoma, 50% died at a mean of 3 years, with tumor size, stage, and anatomic site identified as factors increasing the death rate.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: